InsidersTradesSigma
Follow the Fitlife Brands, INC. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Food & Agriculture sector, Fitlife Brands, INC. has logged 17 public disclosures. Market capitalisation: €101.4m. The latest transaction was filed on 21 August 2026 (Acquisition). Among the most active insiders: Dayton Judd. All data is openly available.
17
Insider Decl.
n/a
Thresholds
€148,776
9 ops.
Buy Volume
€203,582
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Fitlife Brands, INC. Strong Buy (bullish), based on 2 analysts. Average price target: US$17.50.
42Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,892 of 29,064 companies
59.5
score / 100
Value65
Quality54
FCF yld7.8%
Earn yld6.7%
EV/EBITDA13.3x
ROE14%
Gross mgn39%
Net mgn7.8%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 August 2026
Declarations17 total
1,000 shares@ US$10.25Common StockSEC:0002067544-26-000002:0
Canonical exit: 17 Nov 2026 (T+90)
164 shares@ US$15.3601100.0% of flowCommon StockSEC:0001318798-26-000004:0
Canonical exit: 15 Apr 2026 (T+90)
3,000 shares@ US$9.980.029% mcap50.4% of flowCommon StockSEC:0001465378-26-000002:0
Canonical exit: 9 Jul 2026 (T+90)
3,000 shares@ US$9.760.028% mcap28.2% of flowCommon StockSEC:0002033776-26-000002:0
Canonical exit: 9 Jul 2026 (T+90)
300 shares@ US$12.0742.0% of flowCommon StockSEC:0001415889-25-010737:0
Canonical exit: 14 Jul 2025 (T+90)
3,000 shares@ US$12.1750.5% of flowCommon StockSEC:0001415889-25-010736:0
Canonical exit: 13 Jul 2025 (T+90)
2,800 shares@ US$12.174849.5% of flowCommon StockSEC:0001415889-25-009491:0
Canonical exit: 29 Jun 2025 (T+90)
144,000 shares@ US$2.6260.2% of flowCommon StockSEC:0001415889-25-009489:0
2,144 shares@ US$12.6811100.0% of flowCommon StockSEC:0001415889-25-009204:0
150 shares@ US$30.3758.0% of flowCommon StockSEC:0001415889-25-001579:0
Canonical exit: 15 Apr 2025 (T+90)
6,200 shares@ US$0.700.7% of flowCommon StockSEC:0001415889-25-000100:0
4,000 shares@ US$31.0056.2% of flowCommon StockSEC:0001415889-24-015443:0
8,600 shares@ US$0.700.9% of flowCommon StockSEC:0001415889-24-000038:0
4,000 shares@ US$24.5043.8% of flowCommon StockSEC:0001415889-23-016730:0
143,480 shares@ US$1.1527.1% of flowCommon StockSEC:0001415889-23-014014:0
1,000 shares@ US$17.00100.0% of flowCommon StockSEC:0001415889-23-008298:0
Canonical exit: 16 Aug 2023 (T+90)
52,000 shares@ US$0.705.9% of flowCommon StockSEC:0001415889-21-006305:0
17 of 17 declarations
关于 Fitlife Brands, INC.
FitLife Brands, Inc.（股票代码：FTLF）是一家在美国纳斯达克资本市场上市的美国公司，总部位于美国内布拉斯加州奥马哈。对于讲法语的投资者而言，该公司专注于消费者健康、运动营养和健康领域，其商业模式围绕品牌营养补充剂和专有配方而非单一旗舰产品构建。该公司将自己描述为为注重健康的消费者提供创新和专有营养及健身增强产品的供应商，并强调在多个消费者细分市场中以品牌为主导的增长。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000143774926010680/ftlf20251231_10k.htm?utm_source=openai)) FitLife Brands 已开发出涵盖补充剂市场多个子类别的产品组合，包括运动营养、性能、体重管理、消化和更广泛的健康。其 SEC 文件中列出的品牌家族包括 NDS Nutrition、PMD Sports、SirenLabs、Core Active、Nutrology、Metis Nutrition、iSatori、BioGenetic Laboratories、Energize、Dr. Tobias、All Natural Advice、Maritime Naturals、MusclePharm 和 Irwin Naturals。这种多元化的品牌组合使公司能够接触到多个消费者群体，并支持多种市场进入途径，特别是线上销售、批发分销和精选零售合作伙伴。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000143774926010680/ftlf20251231_10k.htm?utm_source=openai)) 从竞争角度来看，FitLife 在一个分散且高度促销的行业中运营，成功取决于品牌认知度、配方差异化、数字营销效率和分销渠道。其对专有产品和健康导向品牌的关注可以支持定价权和客户忠诚度，但该业务也面临着该类别的常见压力：激烈的竞争、不断变化的消费者偏好以及对营销支出和零售商关系的敏感性。最近的 SEC 披露显示，线上收入仍然很重要，而批发渠道也为收入组合做出了有意义的贡献。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000143774926010680/ftlf20251231_10k.htm?utm_source=openai)) 近期的一项重大进展是，在获得美国加利福尼亚中区破产法院批准后，于 2025 年 8 月 8 日完成了对 Irwin Naturals 及其相关附属公司绝大部分资产的收购。此次交易扩大了公司的品牌组合并改变了收入构成，管理层指出，Irwin 的加入降低了线上销售的比例，因为在收购时 Irwin 的线上收入贡献很小。FitLife 的 2025 年年度报告还指出，当年的收入增长主要得益于此次收购。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000143774925025813/ex_850619.htm?utm_source=openai)) 对于投资者而言，关键问题是执行和整合：FitLife 如何有效地吸收被收购品牌、稳定渠道业绩并提高盈利能力，同时管理相对杠杆化的资本结构和竞争激烈的补充剂市场。公司的公开披露，包括 SEC Form 4 内部人交易文件，为监控管理层活动和公司发展势头提供了额外的透明度。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1374328/000203377626000002/xslF345X06/form4-04142026_040403.xml?utm_source=openai))
